Sort
53,477 grants matching “addiction”
Mouse models of stress disorders and addiction
$3,074,342Andrew Holmes · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA
Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain
$3,072,761James N Campbell · Centrexion Therapeutics Corporation · UH3 · FY2023 · NS
Evaluating New Nicotine Standards for Cigarettes
$3,072,358Eric Christian Donny · University Of Pittsburgh At Pittsburgh · U54 · FY2013 · DA
Associative learning, decision-making, and addiction
$3,071,494Geoffrey Schoenbaum · National Institute On Drug Abuse · ZIA · FY2015 · DA
Procurement and Characterization of Postmortem Brain Tissue
$3,068,293Karen Faith Berman · National Institute Of Mental Health · ZIC · FY2013 · MH
Neural circuit dynamics of drug action
$3,065,324Karl Alexander Deisseroth · Stanford University · P50 · FY2019 · DA
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
$3,064,047Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2023 · DA
HEALTH Center for Addictions Research and Cancer Prevention
$3,061,961Bettina M Beech · University Of Houston · U54 · FY2023 · MD
Development of a novel drug for treating opioid use disorder
$3,060,540Nikej Shah · Nirsum Laboratories, Inc. · UG3 · FY2019 · DA
Development of a novel drug for treating opioid use disorder
$3,058,678Nikej Shah · Nirsum Laboratories, Inc. · UG3 · FY2020 · DA
Development of a novel drug for treating opioid use disorder
$3,056,516Nikej Shah · Nirsum Laboratories, Inc. · UH3 · FY2022 · DA
TREATMENT OF ADDICTIONS-BIOLOGICAL CORRELATES
$3,056,419Mary J Kreek · Rockefeller University · P60 · FY2010 · DA
Development of a novel drug for treating opioid use disorder
$3,052,891Nikej Shah · Nirsum Laboratories, Inc. · UH3 · FY2023 · DA
Development of a novel drug for treating opioid use disorder
$3,051,459Nikej Shah · Nirsum Laboratories, Inc. · UH3 · FY2024 · DA
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES
$3,048,429Mary J Kreek · Rockefeller University · P60 · FY2006 · DA
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics
$3,046,519Alan R Buckpitt · Eicosis, Llc · UG3 · FY2020 · DA
Microdialysis Studies of Self-administrationx
$3,043,950Roy A Wise · National Institute On Drug Abuse · Z01 · FY2008 · DA
TREATMENT OF ADDICTIONS-BIOLOGICAL CORRELATES
$3,043,511Mary J Kreek · Rockefeller University · P60 · FY2011 · DA
Characterization of neuronal ensembles activated during cue-induced reward seeking
$3,042,644Bruce Hope · National Institute On Drug Abuse · ZIA · FY2023 · DA
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics
$3,036,135Alan R Buckpitt · Eicosis, Llc · UG3 · FY2019 · DA
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder.
$3,032,676Fiona J. Thomson · Astrazeneca Pharmaceuticals, Lp · UG3 · FY2021 · DA
Biobehavioral Imaging and Molecular Neuropsychopharmacology of Substance Abuse Mechanisms
$3,032,457Michael Michaelides · National Institute On Drug Abuse · ZIA · FY2023 · DA
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder
$3,027,897Paul J Kenny · Eolas Therapeutics, Inc. · UH3 · FY2025 · DA
JCOIN Coordination and Translation Center
$3,026,100Faye S Taxman · George Mason University · U2C · FY2022 · DA
Healthy Brain and Child Development National Consortium Data Coordinating Center
$3,025,233Christopher Daniel Smyser · Washington University · U24 · FY2024 · DA